Acting FDA Commissioner Sharpless on ENDS: topic is a complicated one

Acting FDA Commissioner Sharpless on ENDS: topic is a complicated one

July 12, 2019

U.S. Food and Drug Administration (FDA) Acting Commissioner Ned Sharpless has released a statement on how he plans to regulate e-cigarettes, saying that the FDA oversight of these products is a top priority for the agency.

Some of the FDA’s plans include:

  • Restricting youth access to electronic nicotine-delivery systems (ENDS)
  • Conducting retailer and manufacturer checks
  • Increasing requirements for ENDS manufacturers
  • Utilizing premarket review requirements
  • Providing data to inform premarket applications
  • Preventing youth tobacco use through enforcement actions, policy and education
  • Continuing to invest in more science and research

“While ENDS products appear to hold some promise in helping addicted adult smokers transition away from combustible tobacco to a potentially less harmful form of nicotine delivery, these products are not safe, and we cannot allow the next generation of young people to become addicted to nicotine,” Sharpless said.

Category: Uncategorized

Comments are closed.